|Product Overview:||The VEGF165 agarose resin is produced by introducing rh-VEGF165 functional groups onto the cross-linked agarose matrix. It is designed for the purification of drug molecules which can bind to VEGF165.|
|Matrix:||Highly cross-linked 6% agarose|
|Average particle size:||45-165 μm|
|Ligand concentration:||0.25-1.0 mg/ml|
|Recommended flow rate:||50-150 cm/h|
|Elution buffer:||Buffer I: 0.1 M citric acid, pH 6.0Buffer II: 0.1 M glycine, pH 2.7|
Price does not include shipping and packaging costs.Request quote for final price.